Skip to Main content Skip to Navigation
Journal articles

BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres

Abstract : No abstract available
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-03349131
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Monday, September 20, 2021 - 12:00:16 PM
Last modification on : Friday, October 22, 2021 - 2:50:03 PM

Links full text

Identifiers

`

Citation

Hervé Ghesquières, Cécile Dalban, Emmanuelle Nicolas‐virelizier, Fabrice Jardin, Fabien Le Bras, et al.. BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres. British Journal of Haematology, Wiley, 2021, 192 (3), pp.e94-e98. ⟨10.1111/bjh.17279⟩. ⟨inserm-03349131⟩

Share

Metrics

Record views

47